Inhibition of vascular smooth muscle cell growth by endo- thelial cell-derived heparin. Possible role of a platelet endo- glycosidase. J Biol Chem. 1982;257(19):11256-11260. 29. Clowes AW, Karnowsky MJ. Suppression by heparin of smooth muscle cell proliferation in injured arteries. Nature. 1977;265(5595):625-626. 30. Bhandari M, Hirsh J, Weitz JI, Young E, Venner TJ, Shaughnessy SG. The effects of standard and low molecular weight heparin on bone nodule formation in vitro. Thromb Haemost. 1998;80(3):413-417. 2012 American College of Chest Physicians by Kimberly Henricks on February 10, 2012 chestjournal.chestpubs.org Downloaded from e38S Parenteral Anticoagulants in-vitro and in-vivo effects and implications for the thera- peutic range. Am J Clin Pathol. 1980;74(5):668-673. 68. Baker BA, Adelman MD, Smith PA, Osborn JC. Inability of the activated partial thromboplastin time to predict heparin levels. Time to reassess guidelines for heparin assays. Arch Intern Med. 1997;157(21):2475-2479. 69. Bates SM, Weitz JI, Johnston M, Hirsh J, Ginsberg JS. Use of a xed activated partial thromboplastin time ratio to establish a therapeutic range for unfractionated heparin. Arch Intern Med. 2001;161(3):385-391. 70. Brandt JT, Triplett DA. Laboratory monitoring of hep- arin. Effect of reagents and instruments on the activated partial thromboplastin time. Am J Clin Pathol. 1981;76(4 suppl):530-537. 71. Brill-Edwards P, Ginsberg JS, Johnston M, Hirsh J. Establishing a therapeutic range for heparin therapy. Ann Intern Med. 1993;119(2):104-109. 72. Kitchen S, Jennings I, Woods TA, Preston FE. Wide vari- ability in the sensitivity of aPTT reagents for monitoring of heparin dosage. J Clin Pathol. 1996;49(1):10-14. 73. Olson JD, Arkin CF, Brandt JT, et al. College of American Pathologists Conference XXXI on laboratory monitoring of anticoagulant therapy: laboratory monitoring of unfractionated heparin therapy. Arch Pathol Lab Med. 1998;122(9):782-798. 74. Rosborough TK. Comparing different lots of activated par- tial thromboplastin time reagent: analysis of two methods. Am J Clin Pathol. 1998;110(2):173-177. 75. 